Randomized trial demonstrates high-efficiency synthesis of benzimidazole in a Cu/ZnO catalyst, indicating improved reaction outcomes.
Conventional benzimidazole synthesis faces several challenges, including harsh reaction conditions, the formation of aldehyde‐related byproducts, and a lack of comprehensive mechanistic insights. To address these limitations, we engineered a bifunctional Cu/ZnO catalyst that facilitates high‐efficiency synthesis of benzimidazole while enabling in situ mechanistic monitoring. The spherical ZnO superstructure enhances Lewis acidity (91.2 µmol g −1 ) optimizing the adsorption of o‐arylenediamines. Concurrently, Cu nanoparticles (NPs) promote charge separation, evidenced by a 6‐fold increase in photocurrent and a carrier lifetime of 1.57 ns, while selectively cleaving the α‐C─H bonds of alcohols to generate • CH(R 2 )OH radicals such as • CH(CH 3 )OH. Notably, this radical‐driven pathway circumvents the formation of aldehyde intermediates, achieving a record 2‐methylbenzimidazole (2MBZ) productivity of 3.28 mmol g −1 h −1 with a yield of 98% yield and over 95% stability across five cycles. Furthermore, integrated surface‐enhanced Raman scattering (SERS) spectroscopy provides detailed insights at the single‐particle level, directly capturing transient species, such as radical intermediates (1170 cm −1 ) and Schiff bases (1568 cm −1 ). These findings elucidate the dual role of Cu NPs in both radical adsorption/cross‐coupling and Lewis acid‐mediated stabilization of intermediates. Thus, this work establishes a synergistic strategy that combines high‐efficiency photocatalysis with in situ mechanistic tracking for sustainable heterocycle synthesis.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: